Abstract / Description of output
Achieving consistency in standards of access to and quality of human induced pluripotent stem cells has lagged behind their use. In Europe, a network of academic and industrial partners has been established to overcome this challenge. The experience reveals the devil in the detail of worthy ambitions informing future efforts.
Original language | English |
---|---|
Journal | Trends in biotechnology |
Early online date | 13 May 2017 |
DOIs | |
Publication status | E-pub ahead of print - 13 May 2017 |
Keywords / Materials (for Non-textual outputs)
- Journal Article